151 related articles for article (PubMed ID: 25956854)
1. Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy.
Satsangi A; Roy SS; Satsangi RK; Tolcher AW; Vadlamudi RK; Goins B; Ong JL
Biomaterials; 2015 Aug; 59():88-101. PubMed ID: 25956854
[TBL] [Abstract][Full Text] [Related]
2. Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells.
Satsangi A; Roy SS; Satsangi RK; Vadlamudi RK; Ong JL
Mol Pharm; 2014 Jun; 11(6):1906-18. PubMed ID: 24847940
[TBL] [Abstract][Full Text] [Related]
3. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
4. Functionalized nanospheres for targeted delivery of paclitaxel.
Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
[TBL] [Abstract][Full Text] [Related]
5. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
[TBL] [Abstract][Full Text] [Related]
7. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
8. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
10. Thermosensitive Hydrogel System With Paclitaxel Liposomes Used in Localized Drug Delivery System for In Situ Treatment of Tumor: Better Antitumor Efficacy and Lower Toxicity.
Mao Y; Li X; Chen G; Wang S
J Pharm Sci; 2016 Jan; 105(1):194-204. PubMed ID: 26580704
[TBL] [Abstract][Full Text] [Related]
11. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
12. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
[TBL] [Abstract][Full Text] [Related]
14. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
15. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y
Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
Zhao F; Yin H; Li J
Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
[TBL] [Abstract][Full Text] [Related]
17. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
18. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
[TBL] [Abstract][Full Text] [Related]
19. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model.
Shao W; Paul A; Zhao B; Lee C; Rodes L; Prakash S
Biomaterials; 2013 Dec; 34(38):10109-19. PubMed ID: 24060420
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
